Enrico Agabiti Rosei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Enrico Agabiti Rosei has a total of 297 co-authors. Here are the top co-authors by number of shared publications:
- Maria Lorenza Muiesan
University of Brescia, Brescia, Italy
45 shared publications - Damiano Rizzoni
Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, Italy
31 shared publications - Massimo Salvetti
University of Brescia, Brescia, Italy
22 shared publications E. Porteri
18 shared publicationsE. Agabiti Rosei
17 shared publicationsA. Paini
16 shared publications
Latest Publications
- 1 September 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (Supplement) , e233
[PP.18.01] DECREASED CIRCULATING T REGULATORY LYMPHOCYTES IN OBESE PATIENTS UNDERGOING BARIATRIC SURGERY
It has been previously demonstrated that T lymphocytes may be involved in the development of hypertension and microvascular remodeling, and that circulating T effector lymphocytes may be increased in hypertension (De Ciuceis C et al, Am J Hypertens 2016 Sep 21 online printing; Itani HA et al. Hypertension 2016; 68:123–132). In particular, Th1 and Th 17 lymphocytes may contribute to the progression of hypertension and microvascular damage while TREG lymphocytes seem to be protective. However, no data is avaliable about patients with severe obesity, in which pronounced microvascular alterations were observed (De Ciuceis C et al, Hypertension 2011; 58:29–36). We have investigated 32 severely obese patients undergoing bariatric surgery, as well as 24 normotensive lean subjects and 11 hypertensive lean subjects undergoing an election surgical intervention. No sign of local or systemic inflammation was present in any subject or patient. A peripheral blood sample was obtained before surgery for assessment of CD4+ T lymphocyte subpopulations. Lymphocyte phenotype was evaluated by flow cytometry in order to assess T-effector and T-regulatory (TREG) lymphocytes. Subsets of TREGS were defined as follows: -TREGS recent thymic emigrants (RTE), directly derived from thymus: CD31+; -TREGS naïve: CCR7+CD45RA+; -TREGS central memory (CM): CCR7+CD45RA-; -TREGS effector memory (EM): CCR7-CD45RA-; -TREGS terminal differentiated effector memory (TDEM): CCR7-CD45RA+. Results are summarized in the Table (*p < 0.05, **p < 0.01, ***p < 0.001 vs. lean normotensives; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. lean hypertensives). A marked reduction of several TREG subpopolations was observed in obese patients compared with controls, together with an increased in some T-effector cells. TREG lymphocytes are clearly reduced in severely obese patients, possibly contributing to the development of marked microvascular alterations previously observed in such a population.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (Supplement) , e233
[PP.18.01] DECREASED CIRCULATING T REGULATORY LYMPHOCYTES IN OBESE PATIENTS UNDERGOING BARIATRIC SURGERY
It has been previously demonstrated that T lymphocytes may be involved in the development of hypertension and microvascular remodeling, and that circulating T effector lymphocytes may be increased in hypertension (De Ciuceis C et al, Am J Hypertens 2016 Sep 21 online printing; Itani HA et al. Hypertension 2016; 68:123–132). In particular, Th1 and Th 17 lymphocytes may contribute to the progression of hypertension and microvascular damage while TREG lymphocytes seem to be protective. However, no data is avaliable about patients with severe obesity, in which pronounced microvascular alterations were observed (De Ciuceis C et al, Hypertension 2011; 58:29–36). We have investigated 32 severely obese patients undergoing bariatric surgery, as well as 24 normotensive lean subjects and 11 hypertensive lean subjects undergoing an election surgical intervention. No sign of local or systemic inflammation was present in any subject or patient. A peripheral blood sample was obtained before surgery for assessment of CD4+ T lymphocyte subpopulations. Lymphocyte phenotype was evaluated by flow cytometry in order to assess T-effector and T-regulatory (TREG) lymphocytes. Subsets of TREGS were defined as follows: -TREGS recent thymic emigrants (RTE), directly derived from thymus: CD31+; -TREGS naïve: CCR7+CD45RA+; -TREGS central memory (CM): CCR7+CD45RA-; -TREGS effector memory (EM): CCR7-CD45RA-; -TREGS terminal differentiated effector memory (TDEM): CCR7-CD45RA+. Results are summarized in the Table (*p < 0.05, **p < 0.01, ***p < 0.001 vs. lean normotensives; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. lean hypertensives). A marked reduction of several TREG subpopolations was observed in obese patients compared with controls, together with an increased in some T-effector cells. TREG lymphocytes are clearly reduced in severely obese patients, possibly contributing to the development of marked microvascular alterations previously observed in such a population.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (Supplement) , e74
[OP.7C.11] RELATIONSHIP BETWEEN DIMENSIONS OF THE ASCENDING AORTA AND CLINIC AND 24 HOURS BLOOD PRESSURE IN A GENERAL POPULATION IN NORTHERN ITALY
Epidemiological studies have suggested that even mild enlargement of the ascending aorta may have independent prognostic significance for cardiovascular events. Therefore, some Authors have proposed that dilatation of the ascending aorta could be considered as a form of preclinical vascular damage in hypertensive patients. Aim of our study: was to assess the correlation between clinic and 24 hours BP values and the dimensions of the aorta, measured at level of the sinuses of Valsalva (Val), at the left ventricular outflow tract (LVOT), and at the level of the proximal ascending aorta (AscAO) in subjects from a general population. 250 subjects (43% males, mean age 56 ± 4 years, 42% hypertensives-HT) underwent laboratory examinations, clinic and 24 hours BP measurement, cardiac and carotid ultrasound, carotid-femoral pulse wave velocity measurement (AoPWV). Aortic diameters were greater HT as compared to NT (Val: 3.41 ± 0.54 vs 3.25 ± 0.41 cm, LVOT 2.10 ± 0.28 vs 2.04 ± 0.26, AscAo 3.39 ± 0.45 vs 3.18 ± 0.38, all p < 0.05). Aortic diameters were all correlated to clinic and 24 hours BP values. The coefficients of correlation were greater for 24 hours BP (Tab). Val, AscAo, LVOT were also significantly correlated with left ventricular mass (r = 0.61, r = 0.48, and r = 0.43, all p < 0.001), meanmax intima media thickness (r = 0.13, r = 0.24, and r = 0.13, all p < 0.05) and with AoPWV (r = 0.16, p < 0.05, r = 0.28 p < 0.001, r = 0.08 p = ns). The dimensions of the proximal ascending aorta are significantly related to BP values in normotensive subjects and in hypertensive patients. Aortic dimension are more strictly related to twenty-four hours BP values than to clinic BP values. In this sample of general population a significant correlation between aortic dimensions and measures of cardiac and vascular organ damage was also observed, confirming the parallelism between different forms of organ damage
- 1 September 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (Supplement) , e74
[OP.7C.11] RELATIONSHIP BETWEEN DIMENSIONS OF THE ASCENDING AORTA AND CLINIC AND 24 HOURS BLOOD PRESSURE IN A GENERAL POPULATION IN NORTHERN ITALY
Epidemiological studies have suggested that even mild enlargement of the ascending aorta may have independent prognostic significance for cardiovascular events. Therefore, some Authors have proposed that dilatation of the ascending aorta could be considered as a form of preclinical vascular damage in hypertensive patients. Aim of our study: was to assess the correlation between clinic and 24 hours BP values and the dimensions of the aorta, measured at level of the sinuses of Valsalva (Val), at the left ventricular outflow tract (LVOT), and at the level of the proximal ascending aorta (AscAO) in subjects from a general population. 250 subjects (43% males, mean age 56 ± 4 years, 42% hypertensives-HT) underwent laboratory examinations, clinic and 24 hours BP measurement, cardiac and carotid ultrasound, carotid-femoral pulse wave velocity measurement (AoPWV). Aortic diameters were greater HT as compared to NT (Val: 3.41 ± 0.54 vs 3.25 ± 0.41 cm, LVOT 2.10 ± 0.28 vs 2.04 ± 0.26, AscAo 3.39 ± 0.45 vs 3.18 ± 0.38, all p < 0.05). Aortic diameters were all correlated to clinic and 24 hours BP values. The coefficients of correlation were greater for 24 hours BP (Tab). Val, AscAo, LVOT were also significantly correlated with left ventricular mass (r = 0.61, r = 0.48, and r = 0.43, all p < 0.001), meanmax intima media thickness (r = 0.13, r = 0.24, and r = 0.13, all p < 0.05) and with AoPWV (r = 0.16, p < 0.05, r = 0.28 p < 0.001, r = 0.08 p = ns). The dimensions of the proximal ascending aorta are significantly related to BP values in normotensive subjects and in hypertensive patients. Aortic dimension are more strictly related to twenty-four hours BP values than to clinic BP values. In this sample of general population a significant correlation between aortic dimensions and measures of cardiac and vascular organ damage was also observed, confirming the parallelism between different forms of organ damage
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e246
[PP.21.05] RELATIONSHIP BETWEEN MICROVASCULAR STRUCTURE AND T REGULATORY LYMPHOCYTES OF SMALL RESISTANCE ARTERIES
Objective: Recently it has been demonstrated a role for adaptive immunity, particularly\ud for T regulatory lymphocytes (Tregs), in the development of hypertension\ud and in preventing of angiotensin II–induced vascular injury and infl ammation\ud in animal models (Barhoumi T et al, Hypertension 2011;57:469–476). However,\ud no data are presently available in human beings about possible relationships between\ud Tregs and microvascular structural alterations.\ud Design and method: In the present study we enrolled 11 normotensive subjects\ud and 8 hypertensive patients undergoing an election surgical intervention. All patients\ud underwent a biopsy of subcutaneous fat during surgery. Subcutaneous small\ud resistance artery structure was assessed by wire myography and media to lumen\ud ratio (M/L) was calculated. W/L of retinal arterioles was obtained by Scanning\ud Laser Doppler Flowmetry. Functional (basal) and structural (total) microvascular\ud density were studied by capillaroscopy before and after venous congestion. No\ud sign of local or systemic infl ammation was present in any subjects or patients. We\ud extracted genomic DNA from small resistance arteries and analyzed methylation\ud status of the FoxP3 gene promoter involved in Treg lymphocytes activation. Unmethylated\ud FoxP3 has been demonstrated to be specifi c for Treg lymphocytes. A\ud peripheral blood sample was obtained before surgery for routine chemistry\ud Results: A significant positive correlation was detected between Tregs in small resistance\ud arteries and basal, total and delta gain capillary density in the forearm, whereas no\ud correlations were observed with small resistance artery M/L and retinal arteriole\ud W/L. In addition, a signifi cant inverse correlation was detected between Treg in\ud subcutaneous small vessels and C reactive protein.\ud Conclusions: Our data suggest that Treg lymphocytes detected in subcutaneous\ud small resistance artery wall are related with capillary density and inversely related\ud with infl ammatory markers suggesting a protecting role of Treg also, probably, in\ud terms of angiogenetic properties
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e246
[PP.21.05] RELATIONSHIP BETWEEN MICROVASCULAR STRUCTURE AND T REGULATORY LYMPHOCYTES OF SMALL RESISTANCE ARTERIES
Objective: Recently it has been demonstrated a role for adaptive immunity, particularly\ud for T regulatory lymphocytes (Tregs), in the development of hypertension\ud and in preventing of angiotensin II–induced vascular injury and infl ammation\ud in animal models (Barhoumi T et al, Hypertension 2011;57:469–476). However,\ud no data are presently available in human beings about possible relationships between\ud Tregs and microvascular structural alterations.\ud Design and method: In the present study we enrolled 11 normotensive subjects\ud and 8 hypertensive patients undergoing an election surgical intervention. All patients\ud underwent a biopsy of subcutaneous fat during surgery. Subcutaneous small\ud resistance artery structure was assessed by wire myography and media to lumen\ud ratio (M/L) was calculated. W/L of retinal arterioles was obtained by Scanning\ud Laser Doppler Flowmetry. Functional (basal) and structural (total) microvascular\ud density were studied by capillaroscopy before and after venous congestion. No\ud sign of local or systemic infl ammation was present in any subjects or patients. We\ud extracted genomic DNA from small resistance arteries and analyzed methylation\ud status of the FoxP3 gene promoter involved in Treg lymphocytes activation. Unmethylated\ud FoxP3 has been demonstrated to be specifi c for Treg lymphocytes. A\ud peripheral blood sample was obtained before surgery for routine chemistry\ud Results: A significant positive correlation was detected between Tregs in small resistance\ud arteries and basal, total and delta gain capillary density in the forearm, whereas no\ud correlations were observed with small resistance artery M/L and retinal arteriole\ud W/L. In addition, a signifi cant inverse correlation was detected between Treg in\ud subcutaneous small vessels and C reactive protein.\ud Conclusions: Our data suggest that Treg lymphocytes detected in subcutaneous\ud small resistance artery wall are related with capillary density and inversely related\ud with infl ammatory markers suggesting a protecting role of Treg also, probably, in\ud terms of angiogenetic properties
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e54
[OP.5A.03] RELATIONSHIP BETWEEN LOCAL CAROTID STIFFNESS AND WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e54
[OP.5A.03] RELATIONSHIP BETWEEN LOCAL CAROTID STIFFNESS AND WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e34
[OP.3D.06] RELATIONSHIP BETWEEN DIFFERENT POPULATIONS OF CIRCULATING T LYMPHOCYTES AND MICROVASCULAR OXIDATIVE STRESS
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e34
[OP.3D.06] RELATIONSHIP BETWEEN DIFFERENT POPULATIONS OF CIRCULATING T LYMPHOCYTES AND MICROVASCULAR OXIDATIVE STRESS
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e7
[OP.1B.09] RELATIONSHIP BETWEEN CHA2DS2-VASC SCORE AND PRECLINICAL CARDIOVASCULAR ORGAN DAMAGE IN A GENERAL POPULATION IN NORTHERN ITALY
Objective: Background: The CHA2DS2-VASc score is used in patients with atrial fibrillation (AF) for stroke risk stratification. Recent studies have shown that CHA2DS2-VASc is also predictive of cardiovascular (CV) events and mortality, whether or not AF is present. Few data are available on the relationship between CHA2DS2-VASc and preclinical organ damage (OD) in the general population. Design and method: Aim of our study: was to evaluate the relationship between CHA2DS2-VASc and 10 years Framingham risk scores and preclinical cardiac and vascular organ damage in subjects from a general population. Methods: A total of 478 subjects underwent clinical examination with blood pressure measurement (clinic and 24 hours), and laboratory examinations. Left ventricular (LV) and carotid artery structure were assessed by ultrasound and carotid-femoral PWV was measured. OD was defined according to ESH ESC 2013 Guidelines. CHA2DS2-VASc was calculated as recommended by current AF Guidelines. The Framingham risk score for cardiovascular events (FRS CVD), for stroke (FRS stroke) and for coronary heart disease (FRS CHD) were also calculated. Results: Results: mean age was 58 ± 10 (range 43–74 yrs), 44% were males, 69% hypertensives (37% treated). Left ventricular mass index, meanmax IMT and carotid-femoral pulse wave velocity (PWV) were significantly correlated with all the Framingham risk scores as well as with CHA2DS2-VASc (table).The simultaneous inclusion of CHA2DS2-VASc and FRS (for CVD or Stroke or CHD) in linear regression analysis showed that the relationship between CHA2DS2-VASc and OD is independent of FRS. Conclusions: Conclusions: CHA2DS2-VASc score is significantly correlated to preclinical organ damage in patients from a general population.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e7
[OP.1B.09] RELATIONSHIP BETWEEN CHA2DS2-VASC SCORE AND PRECLINICAL CARDIOVASCULAR ORGAN DAMAGE IN A GENERAL POPULATION IN NORTHERN ITALY
Objective: Background: The CHA2DS2-VASc score is used in patients with atrial fibrillation (AF) for stroke risk stratification. Recent studies have shown that CHA2DS2-VASc is also predictive of cardiovascular (CV) events and mortality, whether or not AF is present. Few data are available on the relationship between CHA2DS2-VASc and preclinical organ damage (OD) in the general population. Design and method: Aim of our study: was to evaluate the relationship between CHA2DS2-VASc and 10 years Framingham risk scores and preclinical cardiac and vascular organ damage in subjects from a general population. Methods: A total of 478 subjects underwent clinical examination with blood pressure measurement (clinic and 24 hours), and laboratory examinations. Left ventricular (LV) and carotid artery structure were assessed by ultrasound and carotid-femoral PWV was measured. OD was defined according to ESH ESC 2013 Guidelines. CHA2DS2-VASc was calculated as recommended by current AF Guidelines. The Framingham risk score for cardiovascular events (FRS CVD), for stroke (FRS stroke) and for coronary heart disease (FRS CHD) were also calculated. Results: Results: mean age was 58 ± 10 (range 43–74 yrs), 44% were males, 69% hypertensives (37% treated). Left ventricular mass index, meanmax IMT and carotid-femoral pulse wave velocity (PWV) were significantly correlated with all the Framingham risk scores as well as with CHA2DS2-VASc (table).The simultaneous inclusion of CHA2DS2-VASc and FRS (for CVD or Stroke or CHD) in linear regression analysis showed that the relationship between CHA2DS2-VASc and OD is independent of FRS. Conclusions: Conclusions: CHA2DS2-VASc score is significantly correlated to preclinical organ damage in patients from a general population.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e320
[PP.32.09] EPISTAXIS
Objective Background: Epistaxis and hypertension are frequent diseases in the adult population. A relationship between the increase of the blood pressure (BP) and the prevalence and incidence of epistaxis has been suggested (Kikidis et al, 2013). Design and method: Aim of our study was to analyze blood pressure changes in patients with active or recent onset epistaxis (<12 hours) from admission to the emergency department (ED) to discharge. Patients and methods: 126 consecutive subjects (84 males, age range 15–93 years, mean age 67 ± 17 years) admitted to the ED (April 2014-February 2015) with primary epistaxis, were prospectively evaluated. BP was measured with an automatic device (OMRON MT10-E) in accordance to ESH-ESC guidelines 2013; measurements were performed at admission to the ED and 30 minutes after the ear, nose and throat (ENT) specialist visit (and possible hemostasis). Results Results: a diagnosis of hypertension was present in 68% of subjects; 75% of them were on antihypertensive treatment, 35% of them reported adequate BP control, 17% had diabetes mellitus and 25% dyslipidemia. A statistically significant reduction in BP was observed from admission to the ED and to the end of ENT evaluation (from 142 ± 21/84 ± 13 mmHg to 135 ± 21/81 ± 13 mmHg, p = 0.001), while no significant changes were observed in heart rate (from 76 ± 15 to 72 ± 13 b/min). Conclusions Conclusions: results obtained in this group of patients with primary epistaxis show a prevalence of hypertension similar to that of a general population. An accurate BP measurement shows a significant reduction at the end of the ENT specialist evaluation compared to baseline measurement, in both hypertensive and normotensive subjects.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e320
[PP.32.09] EPISTAXIS
Objective Background: Epistaxis and hypertension are frequent diseases in the adult population. A relationship between the increase of the blood pressure (BP) and the prevalence and incidence of epistaxis has been suggested (Kikidis et al, 2013). Design and method: Aim of our study was to analyze blood pressure changes in patients with active or recent onset epistaxis (<12 hours) from admission to the emergency department (ED) to discharge. Patients and methods: 126 consecutive subjects (84 males, age range 15–93 years, mean age 67 ± 17 years) admitted to the ED (April 2014-February 2015) with primary epistaxis, were prospectively evaluated. BP was measured with an automatic device (OMRON MT10-E) in accordance to ESH-ESC guidelines 2013; measurements were performed at admission to the ED and 30 minutes after the ear, nose and throat (ENT) specialist visit (and possible hemostasis). Results Results: a diagnosis of hypertension was present in 68% of subjects; 75% of them were on antihypertensive treatment, 35% of them reported adequate BP control, 17% had diabetes mellitus and 25% dyslipidemia. A statistically significant reduction in BP was observed from admission to the ED and to the end of ENT evaluation (from 142 ± 21/84 ± 13 mmHg to 135 ± 21/81 ± 13 mmHg, p = 0.001), while no significant changes were observed in heart rate (from 76 ± 15 to 72 ± 13 b/min). Conclusions Conclusions: results obtained in this group of patients with primary epistaxis show a prevalence of hypertension similar to that of a general population. An accurate BP measurement shows a significant reduction at the end of the ENT specialist evaluation compared to baseline measurement, in both hypertensive and normotensive subjects.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e369
PP.27.13
Objective: Current hypertension guidelines recommend evaluation of preclinical organ damage (OD) for cardiovascular risk assessment. Prevention and/or regression of OD is one of the main goals of antihypertensive treatment. To assess the differences of vascular OD in a large group of hypertensive patients (HT) and normotensive subjects (N) patients according to antihypertensive treatment and blood pressure (BP) control (BP < 140/90 mmHg). Design and method: A total of 319 subjects (mean age 54 ± 7 yrs), 49 % males, 61 % hypertensives (55 % treated), underwent clinical examination with BP measurement (clinic and 24 hours) and standard laboratory examinations. We compared carotido-femoral pulse wave velocity (PWV), ultrasound carotid intima media thickness (IMT) and wall to lumen ratio of retinal arterioles (WLR) among normotensive subjects (N, n = 125), 87 untreated patients with essential hypertension (UHT), 66 treated patients with controlled essential hypertension (TC_HT) and 41 treated patients with uncontrolled essential hypertension (TUC_HT). OD was defined, according to ESH ESC 2013 Guidelines. Results: In TUC_HT a significant increase in retinal WLR (0.33 + 0.19 and 0.23 + 0.13,p = 0.013) and in carotid mean-max IMT (1.62 + 2.9 vs 0.98 + 0.16, p = 0.014) was observed, as compared to normotensive subjects, while no significant differences between TC_HT and NT were demonstrated. In normotensives cfPWV was significantly lower as compared to TUC_HT (p < 0.05), but not as compared to TC_HT. Conclusions: In hypertensive patients, WLR, IMT and aortic stiffness are slightly, but not significantly, increased when blood pressure is controlled. Vascular damage in treated uncontrolled hypertensives might represent the consequence of increased BP, but might also contribute to poor BP control.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e369
PP.27.13
Objective: Current hypertension guidelines recommend evaluation of preclinical organ damage (OD) for cardiovascular risk assessment. Prevention and/or regression of OD is one of the main goals of antihypertensive treatment. To assess the differences of vascular OD in a large group of hypertensive patients (HT) and normotensive subjects (N) patients according to antihypertensive treatment and blood pressure (BP) control (BP < 140/90 mmHg). Design and method: A total of 319 subjects (mean age 54 ± 7 yrs), 49 % males, 61 % hypertensives (55 % treated), underwent clinical examination with BP measurement (clinic and 24 hours) and standard laboratory examinations. We compared carotido-femoral pulse wave velocity (PWV), ultrasound carotid intima media thickness (IMT) and wall to lumen ratio of retinal arterioles (WLR) among normotensive subjects (N, n = 125), 87 untreated patients with essential hypertension (UHT), 66 treated patients with controlled essential hypertension (TC_HT) and 41 treated patients with uncontrolled essential hypertension (TUC_HT). OD was defined, according to ESH ESC 2013 Guidelines. Results: In TUC_HT a significant increase in retinal WLR (0.33 + 0.19 and 0.23 + 0.13,p = 0.013) and in carotid mean-max IMT (1.62 + 2.9 vs 0.98 + 0.16, p = 0.014) was observed, as compared to normotensive subjects, while no significant differences between TC_HT and NT were demonstrated. In normotensives cfPWV was significantly lower as compared to TUC_HT (p < 0.05), but not as compared to TC_HT. Conclusions: In hypertensive patients, WLR, IMT and aortic stiffness are slightly, but not significantly, increased when blood pressure is controlled. Vascular damage in treated uncontrolled hypertensives might represent the consequence of increased BP, but might also contribute to poor BP control.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e369
PP.27.12
Objective: It is was suggested that, in resistant hypertension, the presence of particularly pronounced microvascular alterations may contribute to explain the relative lack of response to treatment. Similarly, in diabetic patients, the persistence of an altered microvasciular structure, despite the administration of multiple drug combination treatment, might partly explain the difficulty to reach target blood pressure values, especially for systolic blood pressure.Design and method: For this reason, we investigated a population of 94 treated essential hypertensive patients. Secondary forms of hypertension were excluded according to standard clinical evalutions and biochemical or instrumental assessment, and in all patients a 24-hour blood pressure monitoring was performed in order to exclude a white coat effect. In all patients, we evaluated small resistance arteries morphology by a wire micromyographic approach (Mulvany's technique). A small amount of subcutaneous tissue was obtained by local biopsy or during election surgery and subcutaneous small resistance arteries were dissected and mounted on a myograph; the media to lumen ratio (M/L) was then measured. We subdived our patents according to the presence or not of resistant hypertension (clinic blood pressure values above 140/90 mm Hg despite administration of three antihypertensive agent including a diuretic and 24-hour blood pressure values > 130/80 mm Hg). Sixteen patients had true resistant hypertension, and were compared with the remaining 78 patients with non-resistant hypertension. Results: Results are summarized in the Table (**p < 0.01, ***p < 0.001 vs. non resistant hypertensive patients). The two groups were also different in terms of mean age (57 ± 12 vs. 67 ± 7 years, p = 0.016 and pulse pressure/stroke volume, a rough index of large artery distensibility: 0.63 ± 0.31 vs. 0.90 ± 0.33, p = 0.02). Conclusions: Our data suggest that hypertensive patients with true resistant hypertension have greater microvascular structural alterations compared with non-resistant hypertensive patients. This could explain, at least in part, the resistance to pharmacological treatment and the high cardiovascular risk observed in these patients.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e369
PP.27.12
Objective: It is was suggested that, in resistant hypertension, the presence of particularly pronounced microvascular alterations may contribute to explain the relative lack of response to treatment. Similarly, in diabetic patients, the persistence of an altered microvasciular structure, despite the administration of multiple drug combination treatment, might partly explain the difficulty to reach target blood pressure values, especially for systolic blood pressure.Design and method: For this reason, we investigated a population of 94 treated essential hypertensive patients. Secondary forms of hypertension were excluded according to standard clinical evalutions and biochemical or instrumental assessment, and in all patients a 24-hour blood pressure monitoring was performed in order to exclude a white coat effect. In all patients, we evaluated small resistance arteries morphology by a wire micromyographic approach (Mulvany's technique). A small amount of subcutaneous tissue was obtained by local biopsy or during election surgery and subcutaneous small resistance arteries were dissected and mounted on a myograph; the media to lumen ratio (M/L) was then measured. We subdived our patents according to the presence or not of resistant hypertension (clinic blood pressure values above 140/90 mm Hg despite administration of three antihypertensive agent including a diuretic and 24-hour blood pressure values > 130/80 mm Hg). Sixteen patients had true resistant hypertension, and were compared with the remaining 78 patients with non-resistant hypertension. Results: Results are summarized in the Table (**p < 0.01, ***p < 0.001 vs. non resistant hypertensive patients). The two groups were also different in terms of mean age (57 ± 12 vs. 67 ± 7 years, p = 0.016 and pulse pressure/stroke volume, a rough index of large artery distensibility: 0.63 ± 0.31 vs. 0.90 ± 0.33, p = 0.02). Conclusions: Our data suggest that hypertensive patients with true resistant hypertension have greater microvascular structural alterations compared with non-resistant hypertensive patients. This could explain, at least in part, the resistance to pharmacological treatment and the high cardiovascular risk observed in these patients.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e118-e119
9A.07
Objective: In patients with systemic lupus erythematosus (SLE) a greater prevalence of structural and functional cardiovascular (CV) alterations has been described, possibly explaining the higher incidence of CV events, as compared to subjects matched for age and sex. Aim of this study was to analyze the presence of target organ damage in premenopausal women with SLE and in controls matched not only for demographic characteristics but also for other cardiovascular risk factors. Design and method: 34 patients with SLE clinically stable (SLEDAI Score 2.5 +/- 1.5) (mean age 32 ± 7 years, range 19–44) and 34 controls matched for sex, age, body mass index (BMI), clinic blood pressure (BP) and antihypertensive treatment (if present), underwent: 24 hours BP monitoring, echocardiography with tissue Doppler analysis (TDI) for the evaluation of left ventricular (LV) structure and of systolic and diastolic function, carotid ultrasound for intima-media thickness (IMT) and carotid distensibility measurement, and pulse wave velocity measurement for aortic stiffness (PWV). Results: By definition no difference was observed for age, sex, BMI and clinic BP values and a similar Framingham risk score was observed between SLE and controls (1.3 ± 2.7 vs 1.5 ± 2.3%, p = ns). No significant differences were observed for all echocardiographic parameters except LV longitudinal systolic function (Sm), an early index of LV systolic dysfunction (see Table). Carotid IMT and distensibility, as well as PWV and the prevalence of an abnormal aortic stiffness were both similar in the two groups. At the logistic analysis, PWV was independently associated with LV mass in controls and with the steroid weekly dose in SLE patients.Conclusions: In patients with SLE and low activity index of the disease we did not observe significant vascular alterations as compared to controls with similar cardiovascular risk. The early LV systolic impairment observed in this group of patients needs confirmation in larger cohorts.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e118-e119
9A.07
Objective: In patients with systemic lupus erythematosus (SLE) a greater prevalence of structural and functional cardiovascular (CV) alterations has been described, possibly explaining the higher incidence of CV events, as compared to subjects matched for age and sex. Aim of this study was to analyze the presence of target organ damage in premenopausal women with SLE and in controls matched not only for demographic characteristics but also for other cardiovascular risk factors. Design and method: 34 patients with SLE clinically stable (SLEDAI Score 2.5 +/- 1.5) (mean age 32 ± 7 years, range 19–44) and 34 controls matched for sex, age, body mass index (BMI), clinic blood pressure (BP) and antihypertensive treatment (if present), underwent: 24 hours BP monitoring, echocardiography with tissue Doppler analysis (TDI) for the evaluation of left ventricular (LV) structure and of systolic and diastolic function, carotid ultrasound for intima-media thickness (IMT) and carotid distensibility measurement, and pulse wave velocity measurement for aortic stiffness (PWV). Results: By definition no difference was observed for age, sex, BMI and clinic BP values and a similar Framingham risk score was observed between SLE and controls (1.3 ± 2.7 vs 1.5 ± 2.3%, p = ns). No significant differences were observed for all echocardiographic parameters except LV longitudinal systolic function (Sm), an early index of LV systolic dysfunction (see Table). Carotid IMT and distensibility, as well as PWV and the prevalence of an abnormal aortic stiffness were both similar in the two groups. At the logistic analysis, PWV was independently associated with LV mass in controls and with the steroid weekly dose in SLE patients.Conclusions: In patients with SLE and low activity index of the disease we did not observe significant vascular alterations as compared to controls with similar cardiovascular risk. The early LV systolic impairment observed in this group of patients needs confirmation in larger cohorts.